MBA
LAW
LANGUAGES

BIOSANTE PHARMA INC BPAX (NASDAQ)

$ 3.15

23:00

Sponsored by

Change: -0.52 (-14.17%)
Volume: 165,000

Avg. Volume:	78540
P/E Ratio:	0
EPS (Annual):	-0.41
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	26,800
Institutional Shareholders:	10.50%

Last:	3.15
Change:	-0.52 (-14.17%)
Prev. Close:	3.67
Open:	3.58
Day's Range:	2.72 - 3.58
52wk Range:	2.05 - 5.86
Market Value:	99,250
Beta:	1.06

12-month EPS Change:	45.83%
Total Return Last 12 Months:	-42.73%
Total Return Last 3 Years:	-42.73%
Total Return Last 5 Years:	-42.73%
5-Year Revenue Growth Rate:	-100.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	-41.18%

Headlines on BPAX

Alert me

Women on antidepressants may benefit from Viagra

(CHICAGO)Viagra's effect in women has been disappointing, but a new small study finds those on antidepressants may benefit from taking the little blue pills. The research involving 98 preme...READ MORE

Jul 22, 2008 7:38PM

Keywords: BPAX

BioSante Pharma retains Deutsche Bank as adviser

(LINCOLNSHIRE, Ill.)BioSante Pharmaceuticals Inc. said Tuesday it hired Deutsche Bank Securities Inc. to advise the company on strategic alternatives. Biosante is developing LibiGel, a topical testost...READ MORE

Jun 10, 2008 10:55AM

Keywords: BPAX, JNJ, AIS, WPI

UVa. Tests Viagra-Like Drug for Women

(CHARLOTTESVILLE, Va.)A drug that could do for women what Viagra has done for men is being tested at the University of Virginia. The drug is a testosterone-laden ointment called LibiGel and it's intende...READ MORE

Dec 31, 2007 6:04PM

Keywords: BPAX